Diabetes Care:糖尿病患者早期控制血压可降低心血管事件发生

2013-05-03 Diabetes Care 丁香园

为了评估早期进行血压控制对伴新发高血压的糖尿病患者主要心血管事件的影响,来自美国明尼阿波里斯市卫生伙伴研究基金会的Patrick J Oconnor博士及其团队进行了一项研究,该研究结果发表在2013年2月的美国《糖尿病治疗》(Diabetes Care)杂志上。该研究发现对新发高血压的糖尿病患者积极行血压控制可带来显著的短期临床获益。该研究中,受试者包括15,665例新近诊断高血压的糖尿病患者,

为了评估早期进行血压控制对伴新发高血压的糖尿病患者主要心血管事件的影响,来自美国明尼阿波里斯市卫生伙伴研究基金会的Patrick J Oconnor博士及其团队进行了一项研究,该研究结果发表在2013年2月的美国《糖尿病治疗》(Diabetes Care)杂志上。该研究发现对新发高血压的糖尿病患者积极行血压控制可带来显著的短期临床获益。
该研究中,受试者包括15,665例新近诊断高血压的糖尿病患者,基线时均无冠心病或脑血管疾病。应用泊松回归模型评价高血压起病1年内合理控制血压能否预测糖尿病患者的主要心血管事件的发生风险。在行模型分析时对基线Framingham风险评分(FRS)和其它协变量分别做校正或非校正处理。
该研究结果表明,受试者平均年龄51.5岁,高血压起病时的平均血压为136.8/80.8mmHg。高血压起病第一年后,平均血压降至131.4/78.0mmHg,其中32.9%受试者血压<130/80 mmHg,80.2%受试者血压<140/90 mmHg,平均随访时间为3.2年。经年龄校正后,1年平均血压<130/80、130-139/80-89、≥140/90 mmHg受试者的主要心血管事件发生率分别为5.10、4.27和6.94个事件数/1000人年(P=0.004)。在FRS校正模型中,起病第一年平均血压≥140/90 mmHg的受试者主要心血管事件发生率显著升高(风险比为1.30 [95% CI 1.01-1.169];P = 0.04)。
该研究发现,高血压发病第一年血压控制不佳可显著增加三年内发生主要心血管事件的可能性。对新发高血压的糖尿病患者积极行血压控制可带来显著的短期临床获益。
糖尿病相关的拓展阅读:


Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes.
OBJECTIVE
To assess the impact of early hypertension (HT) control on occurrence of subsequent major cardiovascular events in those with diabetes and recent-onset HT.
RESEARCH DESIGN AND METHODS
Study subjects were 15,665 adults with diabetes but no diagnosed coronary or cerebrovascular disease at baseline who met standard criteria for new-onset HT. Poisson regression models assessed whether adequate blood pressure control within 1 year of HT onset predicts subsequent occurrence of major cardiovascular events with and without adjustment for baseline Framingham Risk Score (FRS) and other covariates.
RESULTS
Mean age was 51.5 years, and mean blood pressure at HT onset was 136.8/80.8 mmHg. In the year after HT onset, mean blood pressure decreased to 131.4/78.0 mmHg and was <130/80 mmHg in 32.9% of subjects and <140/90 mmHg in 80.2%. Over a mean follow-up of 3.2 years, age-adjusted rates of major cardiovascular events in those with mean 1-year blood pressure measurements of <130/80, 130-139/80-89, and ≥140/90 mmHg were 5.10, 4.27, and 6.94 events/1,000 person-years, respectively (P = 0.004). In FRS-adjusted models, rates of major cardiovascular events were significantly higher in those with mean blood pressure ≥140/90 mmHg in the first year after HT onset (rate ratio 1.30 [95% CI 1.01-1.169]; P = 0.04).
CONCLUSIONS
Failure to adequately control BP within 1 year of HT onset significantly increased the likelihood of major cardiovascular events within 3 years. Prompt control of new-onset HT in patients with diabetes may provide important short-term clinical benefits.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2013-05-13 88gogo

    为什么我看不到评论

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
    2013-05-05 匿名用户

    设计很巧妙

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1643307, encodeId=a032164330ef6, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Sun Mar 09 03:08:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988315, encodeId=feea1988315b5, content=<a href='/topic/show?id=5a5c56e3945' target=_blank style='color:#2F92EE;'>#控制血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56739, encryptionId=5a5c56e3945, topicName=控制血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Thu Jan 02 01:08:00 CST 2014, time=2014-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636656, encodeId=a4351636656b0, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Apr 13 04:08:00 CST 2014, time=2014-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759271, encodeId=b3f41e592711f, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Dec 18 21:08:00 CST 2013, time=2013-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901077, encodeId=bdf619010e704, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Nov 13 09:08:00 CST 2013, time=2013-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5706, encodeId=5e1f5e0648, content=为什么我看不到评论, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=369168418, createdName=88gogo, createdTime=Mon May 13 10:33:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5688, encodeId=fe255688f0, content=设计很巧妙, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun May 05 09:05:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473700, encodeId=d50114e37001c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 07:08:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]

相关资讯

PLoS Med:先兆子痫是糖尿病发病危险因素

  加拿大一项研究表明,对于无妊娠期糖尿病(GDM)、有先兆子痫(PEC)和(或)妊娠期高血压(GH)的女性,在随访至产后16.5年时,其糖尿病发生风险增加了2倍。与仅有GDM者相比,同时患有GDM、PEC和(或)GH者的糖尿病发生风险显著增加。该论文4月16日在线发表于《公共科学图书馆·医学》(PLoS Med)杂志。   该回顾性研究纳入1994年4月至2008年3月期间在加拿大安

NEJM:糖尿病治疗有进展但仍存不足

  《新英格兰医学杂志》4月25日在线发表的一项研究显示,自1999年以来,成人糖尿病治疗在依从预防措施和控制糖尿病并发症危险因素方面取得了明显进展。然而,仍有半数的患者未达到血糖控制、血压和血脂控制目标,并且半数患者表示未接受过糖尿病教育、常被忽视而未接受推荐的每年1次的疫苗接种、牙科检查和眼部检查(N. Engl. J. Med. 2013;368:16

Diabetes Care:ADA与ENDO低血糖共识

    低血糖对糖尿病患者产生的影响一直以来广受关注,美国糖尿病学会(ADA)和美国内分泌学会(ENDO)对既往与新进证据进行回顾,并于近日公布一份共识文件Hypoglycemia and Diabetes: A Report of aWorkgroup of the American Diabetes Association and The Endocrine Society。  

NEJM:美国糖尿病防治十年进展回顾

  近日发表在《新英格兰医学杂志》(NEJM)上的一项研究表明,1999年-2010年美国糖尿病患者降糖达标率提高了8%,将近12%的患者降压达标,21%的患者LDL胆固醇水平降低。然而33%-49%的患者未能降糖达标,每5例糖尿病患者中就有1例未能戒烟。   研究主要负责人Mohammed Ali医生表示,全美患者对糖尿病的阻击取得了缓慢而有成效的进展。 与糖尿病相关的拓展阅读:

AACE2013:糖尿病治疗方案

  AACE日前公布2013年版《糖尿病综合治疗方案》,方便初级保健医生、内分泌科及其他科室医务工作者更好地预防与治疗糖尿病前期与2型糖尿病。 与糖尿病相关的拓展阅读: Diabetes Care:良好的血糖和血压控制有益于延长糖尿病患者生存期 第一时相胰岛素分泌减少是我国2型糖尿病关键诱因 Diabetic Med:高血压患者治疗时HDL低预示新发糖尿病风险更高 美国糖尿病防

Stroke:糖尿病患者缺血性卒中风险或无种族差异

  美国一项研究表明,无论种族如何,糖尿病患者在各年龄段仍表现为卒中风险极大升高,并且在<65岁时尤为显著。论文4月25日在线发表于《卒中》(Stroke)。   既往研究显示在糖尿病患者中缺血性卒中发病率在黑人和白人中升高,尤其是那些年龄<55岁的患者。此项基于人群研究对1993~1994、1999和2005年间年龄≥20岁的黑人和白人中的首次缺血性卒中进行了分析。对性别、种族和年